(Schedules of Concentration of Risk) (Details)	1 Months Ended	6 Months Ended		11 Months Ended	12 Months Ended
	Dec. 29, 2023	Dec. 30, 2022	Jun. 16, 2022	Nov. 14, 2023	Dec. 29, 2023	Dec. 30, 2022	Dec. 31, 2021
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | CuraScript, Inc [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			15.60%				26.10%
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | McKesson Corporation [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	10.80%
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | Amerisource Bergen Corporation [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		10.00%
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | FFF Enterprises, Inc.
Concentration Risk [Line Items]
Concentration risk, percentage	23.10%	26.10%	11.80%	22.30%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | McKesson Corporation [Member]
Concentration Risk [Line Items]
Concentration risk, percentage					20.00%	17.30%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Amerisource Bergen Corporation [Member]
Concentration Risk [Line Items]
Concentration risk, percentage					24.20%	23.30%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | FFF Enterprises, Inc.
Concentration Risk [Line Items]
Concentration risk, percentage						16.20%
Product Concentration Risk | Net Sales Attributable to Products | Acthar Gel
Concentration Risk [Line Items]
Concentration risk, percentage	23.50%	28.30%	25.40%	22.70%			26.90%
Product Concentration Risk | Net Sales Attributable to Products | Inomax
Concentration Risk [Line Items]
Concentration risk, percentage	14.50%	16.70%	19.00%	16.50%			20.30%
Product Concentration Risk | Net Sales Attributable to Products | Therakos
Concentration Risk [Line Items]
Concentration risk, percentage	16.10%	12.50%	12.50%	13.60%			12.10%
Product Concentration Risk | Net Sales Attributable to Products | APAP
Concentration Risk [Line Items]
Concentration risk, percentage	13.40%	10.70%	11.00%	11.40%